ImStem Biotechnology
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis (NCT04956744) | ImStem Biotechnology | 2021-08-31 |
Track ImStem Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.